Literature DB >> 5084818

Activation of arginine and tyrosine esterase in serum from patients with hereditary angio-oedema.

V Eisen, C Loveday.   

Abstract

1. The role of clotting factor XII in the activation of the complement subunit C1s to C1 esterase was examined.2. In sera from patients with hereditary angio-oedema who lack the alpha(2)-glycoglobulin C1 inhibitor, silicates and other potent activators of clotting factor XII induced far less C1 esterase activity than did the weaker factor XII activators, carrageenin and cellulose sulphate. In contrast, the intensity of the induced plasma kallikrein activity corresponded more closely to the clot-promoting effect of the factor XII activators.3. Spontaneous generation of C1 esterase activity was only slightly delayed in hereditary angio-oedema sera previously depleted of factor XII. In normal sera, C1 esterase did not develop spontaneously and could not be induced.4. Experiments with inhibitors suggested that the spontaneous activation of C1s may consist of two phases: factor XII and other plasma proteases first activate small amounts of C1s; the resulting C1 esterase then activates the bulk of C1s. The observed spontaneous activation suggests that when fully activated, the C1s present in 1 ml of human serum will hydrolyse 1-2 mumol of ATEe/minute.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5084818      PMCID: PMC1666111          DOI: 10.1111/j.1476-5381.1972.tb06858.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  E. Complement. The immunochemistry of complement.

Authors:  P J Lachmann
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-07-01

Review 2.  Complement.

Authors:  H J Müller-Eberhard
Journal:  Annu Rev Biochem       Date:  1969       Impact factor: 23.643

Review 3.  Complement in human disease.

Authors:  P H Schur; K F Austen
Journal:  Annu Rev Med       Date:  1968       Impact factor: 13.739

4.  A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid. Studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism.

Authors:  B Lundh; A B Laurell; H Wetterqvist; T White; G Granerus
Journal:  Clin Exp Immunol       Date:  1968-09       Impact factor: 4.330

Review 5.  Hereditary angioneurotic edema: a clinical survey.

Authors:  V H Donaldson; F S Rosen
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

6.  Hageman factor activation and kinin formation in human plasma induced by cellulose sulfate solutions.

Authors:  W F Kellermeyer; R W Kellermeyer
Journal:  Proc Soc Exp Biol Med       Date:  1969-04

7.  The enzymatic nature of C'1r. Conversion of C'1s to C'1 esterase and digestion of amino acid esters by C'1r.

Authors:  G B Naff; O S Ratnoff
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

8.  The conversion of C'IS to C'1 esterase by plasmin and trypsin.

Authors:  O D Ratnoff; G B Naff
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

9.  The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor.

Authors:  O D Ratnoff; J Pensky; D Ogston; G B Naff
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

10.  Mechanisms of activation of C'1 esterase in hereditary angioneurotic edema plasma in vitro.

Authors:  V H Donaldson
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  2 in total

1.  Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives.

Authors:  R S Tedder; M Nelson; V Eisen
Journal:  Br J Exp Pathol       Date:  1975-10

2.  Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.

Authors:  V Eisen; C Loveday
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.